Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
P/FCF Ratio Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
-1.23
↑ 99% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
-109.08
Historical baseline
PeriodValueYoY Change
2024-1.23+99.7%
2023-381.07-1715.5%
2022-20.99+36.4%
2021-33.02-